{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:22Z","timestamp":1778566642044,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Traditional monoaminergic medications often offer limited relief for the physical and cognitive symptoms of post-traumatic stress disorder (PTSD) and complex PTSD. Growing data now point to fast-acting, glutamate-based treatments that boost synaptic plasticity and interrupt fear-conditioned neural circuits. We report four sequential cases of hard-to-treat trauma-spectrum disorders\u2014somatic PTSD, acute bereavement-related PTSD, trauma-linked adolescent depression, and complex PTSD complicated by bipolar II disorder, ADHD, and borderline features\u2014that showed clinically meaningful symptom improvement, typically within days to weeks, with an inexpensive, fully oral protocol centred on dextromethorphan (DXM) potentiated by fluoxetine, with optional add-on piracetam and\/or bupropion. All four patients showed notable reductions in intrusive memories, rumination, somatic pain, and functional disability; no episodes of dissociation, hypertension, or mania were clinically documented during follow-up, although structured screening for hypomania\/mania and serotonergic toxicity was not performed. These findings are strictly hypothesis-generating and broaden the ketamine\/Auvelity framework to trauma-spectrum presentations. They suggest that further controlled investigation into oral NMDA\u2013AMPA modulators may be warranted for trauma-related conditions.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1752101","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:03Z","timestamp":1778564643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-\/bupropion-potentiated dextromethorphan \u00b1 piracetam: a four-patient case series"],"prefix":"10.3389","volume":"17","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[{"name":"Cheung Ngo Medical Limited","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11920-017-0829-z","article-title":"Synaptic loss and the pathophysiology of PTSD: Implications for ketamine as a prototype novel therapeutic","volume":"19","author":"Krystal","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am J Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01606-3","article-title":"Long term structural and functional neural changes following a single infusion of ketamine in PTSD","volume":"48","author":"Duek","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.23.1081","article-title":"Dextromethorphan-bupropion (Auvelity) for the treatment of major depressive disorder","volume":"21","author":"McCarthy","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/PSY.0000000000000010","article-title":"Psychological trauma and functional somatic syndromes: A systematic review and meta-analysis","volume":"76","author":"Afari","year":"2014","journal-title":"Psy Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1037\/0033-2909.130.5.793","article-title":"Psychological mechanisms of medically unexplained symptoms: An integrative conceptual model","volume":"130","author":"Brown","year":"2004","journal-title":"Psychol Bull"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.13070170","article-title":"A neural circuit framework for somatosensory amplification in somatoform disorders","volume":"27","author":"Perez","year":"2015","journal-title":"J Neuropsy Clin Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1091","article-title":"Sexual abuse and lifetime diagnosis of somatic disorders: A systematic review and meta-analysis","volume":"302","author":"Paras","year":"2009","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tins.2011.06.007","article-title":"Fear conditioning, synaptic plasticity and the amygdala: Implications for posttraumatic stress disorder","volume":"35","author":"Mahan","year":"2012","journal-title":"Trends Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1021\/jm901905j","article-title":"Piracetam defines a new binding site for allosteric modulators of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors","volume":"53","author":"Ahmed","year":"2010","journal-title":"J Med Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.01935","article-title":"Eye movement desensitization and reprocessing and slow wave sleep: A putative mechanism of action","volume":"8","author":"Pagani","year":"2017","journal-title":"Front Psychol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.01.026","article-title":"Co-occurring posttraumatic stress and depression symptoms after sexual assault: A latent profile analysis","volume":"149","author":"Au","year":"2013","journal-title":"J Affect Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jad.2017.01.029","article-title":"Heterogeneity in patterns of DSM-5 posttraumatic stress disorder and depression symptoms: Latent profile analyses","volume":"212","author":"Contractor","year":"2017","journal-title":"J Affect Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10608-006-9089-7","article-title":"The role of rumination and reduced concreteness in the maintenance of posttraumatic stress disorder and depression following trauma","volume":"32","author":"Ehring","year":"2008","journal-title":"Cognit Ther Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/da.20228","article-title":"Rumination in posttraumatic stress disorder","volume":"24","author":"Michael","year":"2007","journal-title":"Depress Anxiety"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.2\/jflory","article-title":"Comorbidity between post-traumatic stress disorder and major depressive disorder: Alternative explanations and treatment considerations","volume":"17","author":"Flory","year":"2015","journal-title":"Dial Clin Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v7.29303","article-title":"Broadening perspectives on trauma and recovery: A socio-interpersonal view of PTSD","volume":"7","author":"Maercker","year":"2016","journal-title":"Eur J Psychotraumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04134.x","article-title":"The effect of selective serotonin re-uptake inhibitors on CYP2D6 activity in human liver microsomes","volume":"34","author":"Crewe","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav Brain Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2019.172763","article-title":"Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus","volume":"185","author":"Uniyal","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.09.015","article-title":"Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study","volume":"47","author":"Ghaleiha","year":"2013","journal-title":"J Psychiatr Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.11.064","article-title":"Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies","volume":"649","author":"Averill","year":"2017","journal-title":"Neurosci Lett"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7045","article-title":"Improvement of depressive symptoms, after a suicide attempt, with dextromethorphan\/bupropion combination treatment in a patient with treatment-resistant depression and psychiatric comorbidities","volume":"11","author":"Pedraz-Petrozzi","year":"2023","journal-title":"Clin Case Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.31405323.v1","article-title":"The pruning-vulnerability cascade in PTSD: Convergent evidence for developmental synaptic and myelin dysregulation","author":"Cheung","year":"2026","journal-title":"Figshare"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17940803","article-title":"Resolution of chronic derealisation and fugue-like episodes in routine outpatient care: A case report regarding the NMDA-AMPA axis","author":"Cheung","year":"2025","journal-title":"Zenodo"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17940848","article-title":"Slow remission of complex PTSD with intermittent exacerbations: A case-oriented review on trauma and neuroplasticity","author":"Cheung","year":"2025","journal-title":"Zenodo"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17941467","article-title":"Targeting the NMDA\u2013AMPA axis to restore synaptic plasticity in trauma-related disorders: Mechanistic principles and clinical observations","author":"Cheung","year":"2025","journal-title":"Zenodo"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202511.2246.v1","article-title":"Clinical experience and optimisation of the Cheung glutamatergic regimen for refractory psychiatric diseases","author":"Cheung","year":"2025","journal-title":"Preprints"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18006065","article-title":"An oral ketamine-like approach to treatment-resistant obsessive-compulsive disorder \u2013 A review of mechanism, clinical experience, and future directions","author":"Cheung","year":"2025","journal-title":"Zenodo"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1752101\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:10Z","timestamp":1778564650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1752101\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":33,"alternative-id":["10.3389\/fpsyt.2026.1752101"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1752101","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1752101"}}